Introduction In the past decade, the atrial fibrillation (AF) landscape, including the treatment
modalities, has drastically changed. This raises the question how AF prevalence and …

Background For the improvement of AF care, it is important to gain insight into current
anticoagulation prescription practices and guideline adherence. This report focuses on the …

Abstract Background: AF, anticoagulation, NOACs, changing patterns of prescription.
Methods: We describe baseline data and treatment patterns of patients recruited in Belgium …

Background To assess baseline characteristics, drug utilisation and healthcare use for oral
anticoagulants (OACs) following the introduction of non-vitamin K antagonist oral …

Objectives To investigate the prevalence of atrial fibrillation (AF), the proportion of AF
patients not receiving oral anticoagulation (OAC) and reasons for abstaining from OAC …

Aim Non‐vitamin K antagonist oral anticoagulants (NOACs) are increasingly preferred over
vitamin K antagonists (VKAs) in atrial fibrillation (AF) management. However, differences in …

Objectives To determine the prevalence of atrial fibrillation (AF) and to assess how these
patients are being cared for: what anticoagulants are being prescribed and are they being …

Background In the Dutch atrial fibrillation (AF) guideline for GPs, vitamin K antagonists
(VKAs) and direct oral anticoagulants (DOACs) are seen as equivalent, while in cardiology …

Background In the Dutch atrial fibrillation (AF) guideline for GPs, vitamin K antagonists
(VKAs) and direct oral anticoagulants (DOACs) are seen as equivalent, while in cardiology …

Objective Atrial fibrillation (AF) is the most common cardiac arrhythmia and an important risk
factor for stroke. Treatment with anticoagulants substantially reduces risk of stroke. Current …